1. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial. Issue 8 (August 2019) Authors: Herbst, Roy S; Arkenau, Hendrik-Tobias; Santana-Davila, Rafael; Calvo, Emiliano; Paz-Ares, Luis; Cassier, Philippe A; Bendell, Johanna; Penel, Nicolas; Krebs, Matthew G; Martin-Liberal, Juan; Isambert, Nicolas; Soriano, Andres; Wermke, Martin; Cultrera, Jennifer; Gao, Ling; Widau, Ryan C; Mi, Gu;... Journal: Lancet oncology Issue: Volume 20:Issue 8(2019) Page Start: 1109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF). (31st May 2018) Authors: Arkenau, Hendrik‐Tobias; Martin‐Liberal, Juan; Calvo, Emiliano; Penel, Nicolas; Krebs, Matthew G.; Herbst, Roy S.; Walgren, Richard A.; Widau, Ryan C.; Mi, Gu; Jin, Jin; Ferry, David; Chau, Ian Journal: Oncologist Issue: Volume 23:Number 12(2018) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ). (September 2020) Authors: Bang, Yung-Jue; Golan, Talia; Dahan, Laetitia; Fu, Siqing; Moreno, Victor; Park, Keunchil; Geva, Ravit; De Braud, Filippo; Wainberg, Zev A.; Reck, Martin; Goff, Laura; Laing, Naomi; Mi, Gu; Oliveira, Joana M.; Wasserstrom, Heather; Lin, Chia-Chi Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enhancement of the adaptive signature design for learning and confirming in a single pivotal trial. (5th May 2017) Authors: Mi, Gu Journal: Pharmaceutical statistics Issue: Volume 16:Number 5(2017) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗